21/04/2020 : Information on the Annual General Meeting to be held in closed session on Thursday, May 14, 2020

Croissy-Beaubourg, April 21, 2020, 5:45pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specialized in in vitro diagnostics and theranostics, hereby confirms the holding of its Annual General Meeting on May 14, 2020 at…

Continue Reading 21/04/2020 : Information on the Annual General Meeting to be held in closed session on Thursday, May 14, 2020

18/03/2020 : Theradiag reports significant improvement in 2019 full-year results

2019 revenue up 10.3% for theranostics and up 6.4% for IVD Continued improvement in operating income and net income before non-recurring items Positive net income partly driven by non-recurring instrumentation sales. Profits reinvested in development…

Continue Reading 18/03/2020 : Theradiag reports significant improvement in 2019 full-year results

09/03/2020 : THERADIAG announces the CE marking for the first four i-Tracker® test kits in its TRACKER® range

Croissy-Beaubourg, March 9, 2020, 6:00 pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that it has CE marked the first four i-Tracker® test kits…

Continue Reading 09/03/2020 : THERADIAG announces the CE marking for the first four i-Tracker® test kits in its TRACKER® range